 |
 |
 |
 |
 |
 |
 |
 |
E-Mail
ShareLiver Complications in HIV-Infected Patients
- Fatal Liver Failure Still 8 Times More Common With HIV in Large US Cohort (July 19, 2010)
From National AIDS Treatment Advocacy Project - Liver Death Rate in Spain Similar With and Without HIV, but Only in HCV-Negative (July 19, 2010)
From National AIDS Treatment Advocacy Project - HIV and Inflammation: A New Threat (Spring 2010)
In Achieve, from ACRIA and GMHC - HIV Load Tied to Fibrosis Signal in Women Without Hepatitis or Alcohol Abuse (February 19, 2010)
From National AIDS Treatment Advocacy Project - RNA Spikes Predict Heart Disease, CD4s Predict Liver and Kidney Disease (February 18, 2010)
From National AIDS Treatment Advocacy Project - Safety Risk Associated With HIV Drug Videx (February 2, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Combining Sustiva + Viread May Increase Liver Risk, Case Reports Suggest (May 9, 2008)
In aidsmap.com - Updates to Prezista (Darunavir) Tablets Labeling (March 11, 2008)
From U.S. Food and Drug Administration - Non-Alcoholic Fatty Liver Disease Is Common in HAART-Experienced Patients; Several HIV- and Antiretroviral-Related Factors May Play Role (February 6, 2008)
From The Body PRO - Immune Reconstitution May Trigger Hepatic Flares in HIV/Hepatitis B Coinfected Patients Starting HAART (February 5, 2008)
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Rapid Liver Fibrosis Occurring More Frequently Among HIV-Infected Men Newly Coinfected With Hepatitis C (February 4, 2008)
An interview with Daniel Fierer, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - The Liver in HIV Disease (December 4, 2007)
Translating HIV research into practice.
From The Body PRO - Tipranavir/Ritonavir-Associated Hepatotoxicity Common, But Resolves Over Time (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Antiretroviral Exposure Not Associated With Liver-Related Deaths in D:A:D Cohort (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - More Questions Than Answers Regarding High Hepatic Event Rates Among Thai Patients in 2NN Study (December 17, 2005)
[Archived Article]
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy - Liver Disease Is Now Leading Cause of Death Among HIV-Positive British Hemophiliacs (September 22, 2005)
[Archived Article]
From aidsmap.com - Hepatitis Testing Important for HIVers Before Taking Kaletra (October 13, 2004)
[Archived Article]
From aidsmap.com - Hepatitis/HIV Coinfection Linked to Liver Complications in Kaletra Patients (September 2004)
[Archived Article]
Abstract of a study that recommends testing HIV-infected patients for HBV and HCV and measuring their baseline ALT values before lopinavir/ritonavir therapy is begun.
In HIV Medicine - Response to Lopinavir/Ritonavir in HIV-Infected Patients Coinfected With Hepatitis C and/or Hepatitis B (July 12, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO - Nevirapine Hepatotoxicity Risks Clarified in New Letter to Healthcare Professionals (PDF) (February 2004)
[Archived Article]
From Boehringer Ingelheim - Liver Damage a Concern for HAART Patients With Hepatitis C, Low CD4 (May 1, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Low Incidence of Grade III/IV Hepatotoxicity in First HAART: Observations From 1,100 Patients Followed for 1 Year (July 9, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO - Antiretrovirals and Liver Toxicity: How Big a Concern? (Summer 2002)
[Archived Article]
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America - Severe Liver Damage With TB Drugs (May 29, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.